Home › US top court won't review J&J-Abbott patent case
 

Keywords :   


US top court won't review J&J-Abbott patent case

2012-02-22 05:29:21| Biotech - Topix.net

The U.S. Supreme Court on Tuesday declined to review a ruling that Abbott Laboratories' Humira arthritis drug did not infringe a patent owned by a Johnson & Johnson subsidiary and that threw out a $1.67 billion damage award against Abbott.

Tags: top case review court

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
19.05GSK-owned Stiefel Labs loses $1.5M verdict in stock value suit
19.05Hepatitis C tests urged for all baby boomers
19.05A-TEK, Inc. Awarded National Institutes of Health $20 Billion CIO-SP3 Contract
19.05Pfizer Recalls Advil Liqui-Gels
19.05Drowning is Leading Cause of Accidental Death for Children
19.05Investment Extra: Boost for British biotech firm ImmuPharma
18.05Test All Baby Boomers for Hepatitis C, CDC Urges
18.05Maryland doctors probe old cases for lead exposure
Biotechnology and Pharmaceuticals »
20.05RIP Aero Glass; Windows 8 Sticks a Fork in Familiar UI
20.05Canadian Pacific workers give 72 hour strike notice as negotiations continue
20.05PNM: Bids show new pollution controls too costly
20.05Real estate agents seeing multiple bids return to Louisville market
20.05Florence real estate market showing signs of life
20.05McCrory campaign wants TV ad pulled
20.05China to Google: Android must remain open
20.05Floating Farewell to WW II Battleship Sunday
More »